Organizational ethics and the high cost of medicines
| dc.contributor.author | Candilis, Philip J. | |
| dc.date | 2022-08-11T08:10:24.000 | |
| dc.date.accessioned | 2022-08-23T17:07:16Z | |
| dc.date.available | 2022-08-23T17:07:16Z | |
| dc.date.issued | 2000-12-01 | |
| dc.date.submitted | 2011-03-01 | |
| dc.identifier.citation | HEC Forum. 2000 Dec;12(4):303-10. | |
| dc.identifier.issn | 0956-2737 (Linking) | |
| dc.identifier.pmid | 11138249 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/45299 | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11138249&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1023/A:1008972917960 | |
| dc.subject | Adult | |
| dc.subject | Antipsychotic Agents | |
| dc.subject | Diabetes Mellitus, Type 2 | |
| dc.subject | *Drug Costs | |
| dc.subject | Drug Industry | |
| dc.subject | *Ethics, Institutional | |
| dc.subject | *Financing, Personal | |
| dc.subject | Humans | |
| dc.subject | Hypoglycemic Agents | |
| dc.subject | Male | |
| dc.subject | Medically Uninsured | |
| dc.subject | *Patient Compliance | |
| dc.subject | Schizophrenia | |
| dc.subject | United States | |
| dc.subject | care | |
| dc.subject | Bioethics and Medical Ethics | |
| dc.subject | Health Services Research | |
| dc.subject | Psychiatry | |
| dc.title | Organizational ethics and the high cost of medicines | |
| dc.type | Journal Article | |
| dc.source.journaltitle | HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues | |
| dc.source.volume | 12 | |
| dc.source.issue | 4 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/psych_cmhsr/398 | |
| dc.identifier.contextkey | 1833495 | |
| dc.identifier.submissionpath | psych_cmhsr/398 | |
| dc.contributor.department | Department of Psychiatry | |
| dc.source.pages | 303-10 |